![](/wp-content/uploads/2023/08/Screenshot-2024-02-14-at-1.02.42-PM.png)
$599
Tandem, Lexicon, and Amgen Q2 ‘23 Earnings
Three cardiometabolic-related news items have been observed: Tandem Diabetes Care (view press release), Lexicon (view press release), and Amgen (press release; slides) hosted their respective Q2 ‘23 earnings calls. Below, FENIX provides highlights and insights into the respective news items.